Chemi Pharmaceutical cries sabotage after licence suspension

By Gareth Macdonald

- Last updated on GMT

Chemi cries sabotage after Health Canada suspends licence
Chemi cries sabotage after Health Canada suspends licence

Related tags: Medicine

Chemi Pharmaceutical CEO says sabotage by former employee behind accusations of falsified test results that prompted Canadian regulators to suspend license. 

Health Canada suspended​ Chemi’s ‘establishment license’ earlier this week, reporting that it discovered evidence the Ottawa-based contract testing laboratory had falsified results during an inspection late last month.

Sean Upton, Health Canada’s senior regulations officer told Outsourcing-pharma.com “The most recent inspection took place on Nov. 22 and 23 at a location in Mississauga, Ontario.

"Test results were falsified or in some instances, no tests were performed and results were made up," ​He said, adding that “11 companies had products tested at the facility that may require further testing.

Upton went on to say that another 15 companies whose products were analysed at the Chemi lab "have indicated that the compromised testing procedures do not require them to halt sales​."  

While it has not received evidence of any adverse events related to the improperly tested products, Health Canada has asked the 11 companies​ involved to temporarily stop selling them until their safety can be confirmed through re-testing.

Upton confirmed this and told us that: “There is no set timeline for the investigation​.”

UPDATE: Health Canada told Outsourcing-pharma.com that as of 12/12/2012 only nine products made by four companies need to be retested.


In a development late yesterday, Chemi president Mariana Stavrikov has alleged that her firm is a victim of sabotage and called on Health Canada to reinstate its establishment license.

Stavrikov told Canada’s CBC news that: “Our history was transparent, clear and fully compliant with [Good Manufacturing Practice] regulations,” adding that "unfortunately, I was subject to a sabotage."

She also told the country’s SunNews​ that a similar story, attributing the actions to an ex-manager who she alleged had been “somewhat aggressive in nature against employees and he had them sign documents supporting his reports.”

She also alleged this employee had falsified test results and then notified Health Canada prompting the visit by Health Canada.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us


View more